BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3551524)

  • 21. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative performance of two copper IUDs: Nova-T and MLCu375.
    de Castro A; Anguiano JM
    Adv Contracept; 1986 Jun; 2(2):155-9. PubMed ID: 3535433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of danazol on the function of the estrogen and progesterone receptor systems of the human endometrium].
    Adamian LV; Alekseeva ML; Zhukova NN; Minina LS; Novikov EA
    Biull Eksp Biol Med; 1988 Feb; 105(2):165-6. PubMed ID: 3349144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Copper-IUD on the human endometrium (author's transl)].
    Tamaya T; Nakata Y; Nioka S; Obata T; Higashiyama S; Okada H
    Nihon Funin Gakkai Zasshi; 1978 Jan; 23(1):24-7. PubMed ID: 627299
    [No Abstract]   [Full Text] [Related]  

  • 27. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
    Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural signs of an interference in the carbohydrate metabolism of human endometrium produced by the intrauterine copper-T device.
    Nilsson O; Hagenfeldt K; Johannisson E
    Acta Obstet Gynecol Scand; 1974; 53(2):139-49. PubMed ID: 4822346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of copper and platinum intrauterine devices on endometrial morphology and implantation in the rabbit.
    Tobert JA; Davies DR
    J Reprod Fertil; 1977 May; 50(1):53-9. PubMed ID: 864653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of copper in vivo on specific progesterone binding by human endometrial cytosol.
    Bonaventura LM; Cleary RE; Young PC
    Fertil Steril; 1979 Nov; 32(5):531-5. PubMed ID: 499584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased endometrial HOXA10 expression associated with use of the copper intrauterine device.
    Tetrault AM; Richman SM; Fei X; Taylor HS
    Fertil Steril; 2009 Dec; 92(6):1820-4. PubMed ID: 18930214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of microRNAs in human endometrium after implantation of an intrauterine contraceptive device containing copper.
    Fan X; Huang J; Xu C; Bao M; Xia W; Zhu C
    Mol Hum Reprod; 2021 Sep; 27(9):. PubMed ID: 34427668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Chlamydia trachomatis growth in endometrial cells by copper: possible relevance for the use of the copper IUD.
    Kleinman D; Sarov I; Insler V
    Contraception; 1989 Jun; 39(6):665-76. PubMed ID: 2666020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-amylase, glycogen synthetase and phosphorylase in the human endometrium: influence of the cycle and of the Cu-T device.
    Robles F; López de la Osa E; Lerner U; Johannisson E; Brenner P; Hagenfeldt K; Diczfalusy E
    Contraception; 1972 Nov; 6(5):373-84. PubMed ID: 4631777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
    Andersson K; Odlind V; Rybo G
    Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of levonorgestrel intrauterine device on human endometrial estrogen and progesterone receptors].
    Lu SM
    Zhonghua Fu Chan Ke Za Zhi; 1991 Sep; 26(5):293-4, 323. PubMed ID: 1935411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifteen years' experience with the Multiload IUD.
    Van Os WA; Edelman DA
    Adv Contracept; 1988 Sep; 4(3):165-78. PubMed ID: 3071108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.